<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The efficacy of a <z:chebi fb="0" ids="44185">methotrexate</z:chebi> (MTX) block/<z:chebi fb="0" ids="17748">thymidine</z:chebi> release synchronization technique has been assessed in bone marrow cultures from patients with <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast to cultures of stimulated lymphocytes from <z:mpath ids='MPATH_458'>normal</z:mpath> individuals, no improvement in mitotic index (MI) or metaphase quality could be detected using this technique </plain></SENT>
<SENT sid="2" pm="."><plain>Demonstration of an unchanged level of division in bone marrow cultures in the presence of MTX suggests that the technique is unsuitable for synchronization purposes in this tissue </plain></SENT>
<SENT sid="3" pm="."><plain>The influence of preincubation prior to MTX exposure and duration of exposure to colcemid on MI and metaphase quality have also been examined </plain></SENT>
</text></document>